18 results
6-K
TAK
Takeda Pharmaceutical Co
2 Feb 24
Current report (foreign)
6:16am
of thrombocytopenia by 60%, as compared to plasma-based therapy (hazard ratio [HR] 0.40; 95% confidence interval [CI]; 0.3- 0.7). Treatment-emergent … ), at a median follow-up of 14.3 months for the PFS ITT (intent-to-treat) population (n=400), the hazard ratio (HR) was 0.65 (95% confidence interval [CI
6-K
TAK
Takeda Pharmaceutical Co
30 Oct 23
Current report (foreign)
6:02am
by 60%, as compared to plasma-based therapy (hazard ratio [HR] 0.40; 95% confidence interval [CI]; 0.3- 0.7). Treatment-emergent adverse events (TEAEs
6-K
TAK
Takeda Pharmaceutical Co
1 Aug 23
Current report (foreign)
6:10am
. TAK-755 also reduced the incidence of thrombocytopenia by 60%, as compared to plasma-based therapy (hazard ratio [HR] 0.40; 95% confidence interval
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
23 Jun 23
Current report (foreign)
6:13am
in the risk of death (hazard ratio [HR] 0.59; 95% confidence interval [CI]: 0.396 to 0.879), with an estimated OS rate (95% CI) of 93.9% (91.6, 95.5) at 6 years
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
30 May 23
Current report (foreign)
6:11am
of death (hazard ratio [HR] 0.59; 95% confidence interval [CI]: 0.396 to 0.879), with an estimated OS rate (95% CI) of 93.9% (91.6, 95.5) at 6 years
6-K
qoeqexo bkx
4 Nov 22
Current report (foreign)
6:01am
6-K
ehzfrzwn7i9
4 Aug 22
Current report (foreign)
6:07am
6-K
60vcjq2
7 Sep 21
Current report (foreign)
6:02am
6-K
EX-99.1
9fcnhgpu9rrein2i45ud
29 Jun 21
Current report (foreign)
7:38am
6-K
EX-99.1
pa0d112v8p5
28 May 21
Current report (foreign)
6:01am
6-K
2yxwcxvz0vbukt4j1
12 Feb 21
Current report (foreign)
6:04am
6-K
EX-99.1
b18c15cbvey5i22kpv
17 Dec 20
Current report (foreign)
6:01am
6-K
ekhdt22fz
10 Nov 20
Current report (foreign)
6:01am
6-K
EX-1
ocl81f4 e9jwprn
27 May 20
Current report (foreign)
6:03am
6-K
hzamuv
13 Feb 20
Current report (foreign)
6:05am
6-K
EX-99.1
39sl34auhzt
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
6-K
EX-99.1
72wsn jc2srp5kccu
21 Nov 19
Current report (foreign)
6:08am
6-K
EX-99.1
e3dfr p89qx3sgz
14 Nov 19
Current report (foreign)
6:26am
- Prev
- 1
- Next